Cerebrovascular Disease - Pipeline Review, H2 2012 New Report
Cerebrovascular Disease - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cerebrovascular Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cerebrovascular Disease. Cerebrovascular Disease - Pipeline Review, Half Year is built using data and information sourced from databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites...
View full press release